Menu
Recruiting NCT05972343

COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients

Observational Breast Cancer Cancer of the Breast

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Cryoablation.
Who it may be relevant to
Registry conditions: Breast Cancer, Cancer of the Breast. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients: A Prospective Observational Registry

Overview

This is a subject registry study of patients who undergo cryoablation for their breast cancer after being determined not to be surgical candidates. Data collected as part of this registry will be used to assess the safety of percutaneous ultrasound-guided cryoablation in this population as well as provide long-term follow-up of subjects who received cryoablation.

Interventions

  • Device Cryoablation
    Takes place at single time point.

Primary outcome measures

  • Proportion of patients who are free of serious treatment related complications per CTCAE v 5.0 [Time frame: Through 3 year follow-up]
Secondary outcome measures (3)
  • Proportion of patients who demonstrate progression-free survival (PFS) [Time frame: At 3 year follow-up]
  • Proportion of patients who demonstrate disease-free survival (DFS) [Time frame: At 3 year follow-up]
  • Proportion of patients who demonstrate overall survival (OS) [Time frame: At 3 year follow-up]

Eligibility criteria

Eligibility Criteria:

  • Diagnosis of breast cancer.
  • Mass must be visible on ultrasound and > 5 mm from skin.
  • Not undergoing surgery, because:
  • Patient has a medical condition that would not allow sedation or general anesthesia
  • Surgery is not clinically indicated due to unresectable and/or metastatic disease
  • Surgery is not clinically indicated for another reason
  • Patient declines surgery
  • At least 18 years old.
  • Able to understand and willing to sign an IRB-approved written informed consent document.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

United States · 1 center
  • Washington University School of Medicine — St Louis

Identifiers

NCT: NCT05972343 · 202307067

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗